XML 12 R39.htm IDEA: XBRL DOCUMENT

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Summary Of Segment Performance



		For the Three Months Ended September 30,
			CAG		Water			LPD			Other			Unallocated Amounts			Consolidated Total
2015
Revenue		$	344,081		$	25,957		$	30,448		$	5,901		$	-		$	406,387

Income (loss) from operations		$	61,541		$	12,408		$	5,562		$	635		$	(8,251)		$	71,895
Interest expense, net																		(7,066)
Income before provision for income taxes																		64,829
Provision for income taxes																		20,600
Net income																		44,229
Less: Net income attributable to noncontrolling interest																		6
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	44,223

2014
Revenue		$	317,309		$	25,747		$	33,063		$	7,404		$	-		$	383,523

Income (loss) from operations		$	60,176		$	11,367		$	6,319		$	794		$	(6,467)		$	72,189
Interest expense, net																		(3,981)
Income before provision for income taxes																		68,208
Provision for income taxes																		16,045
Net income																		52,163
Less: Net income attributable to noncontrolling interest																		21
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	52,142


		For the Nine Months Ended September30,
			CAG		Water			LPD			Other			Unallocated Amounts			Consolidated Total
2015
Revenue		$	1,020,232		$	72,706		$	93,777		$	15,492		$	-		$	1,202,207

Income (loss) from operations		$	181,845		$	33,821		$	17,408		$	204		$	(277)		$	233,001
Interest expense, net																		(19,645)
Income before provision for income taxes																		213,356
Provision for income taxes																		65,611
Net income																		147,745
Less: Net income attributable to noncontrolling interest																		16
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	147,729

2014
Revenue		$	938,166		$	71,655		$	104,581		$	19,446		$	-		$	1,133,848

Income (loss) from operations		$	181,104		$	29,547		$	25,385		$	1,134		$	(11,716)		$	225,454
Interest expense, net																		(8,761)
Income before provision for income taxes																		216,693
Provision for income taxes																		60,693
Net income																		156,000
Less: Net income attributable to noncontrolling interest																		55
Net income attributable to IDEXX Laboratories, Inc. stockholders																	$	155,945

Summary Of Revenue By Product And Service Category


		For the Three Months Ended						For the Nine Months Ended
		September 30,						September 30,
			2015			2014			2015			2014
CAG segment revenue:
CAG Diagnostics recurring revenue:		$	290,502		$	274,367		$	869,413		$	807,193
IDEXX VetLab® consumables			98,957			90,975			298,093			264,410
VetLab service and accessories			13,675			13,537			41,223			40,036
Rapid assay products			47,534			46,777			143,353			139,328
Reference laboratory diagnostic and consulting services			130,336			123,078			386,744			363,419
CAG Diagnostics capital - instruments			25,989			18,215			70,166			55,799
Customer information management and digital imaging systems			27,590			24,727			80,653			75,174
CAG segment revenue			344,081			317,309			1,020,232			938,166

Water segment revenue			25,957			25,747			72,706			71,655
LPD segment revenue			30,448			33,063			93,777			104,581
Other segment revenue			5,901			7,404			15,492			19,446
Total revenue		$	406,387		$	383,523		$	1,202,207		$	1,133,848